Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016, in San Francisco. Giovanni Caforio, chief executive officer, will make a formal presentation about the company at 9:30 a.m. PST (12:30 p.m. EST).

Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160105005210/en/

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
John Elicker, 609-252-4611
[email protected]
or
Ranya Dajani, 609-252-5330
[email protected]
or
Bill Szablewski, 609-252-5894
[email protected]

Source: Bristol-Myers Squibb

You May Also Be Interested In

• UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
• iAsk AI Launches New Education-Based Hub to Help Students Learn with Artificial Intelligence
• Crypto News: Hyperliquid, TRUMP Memecoin, and MemeToro Shape the 2026 Altcoin Market